Novartis CEO Jimenez sees U.S. pricing power draining away

Carly Helfand

Remember the days when drugmakers could raise prices without sparking political pushback? CEO Joe does–and he says they're not coming back.

FiercePharma News

Share This Post

Related Articles

Leave a Reply

© 2017 Global Regulatory Science. All rights reserved. Site Admin · Entries RSS · Comments RSS